The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Janssen
Travel, Accommodations, Expenses - AstraZeneca
Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer: Preliminary analysis of the PePiTA study.
 
Alain Hendlisz
No Relationships to Disclose
 
Rafael Caparica
No Relationships to Disclose
 
Amélie Deleporte
No Relationships to Disclose
 
Jean-Luc Van Laethem
No Relationships to Disclose
 
Philippe Vergauwe
No Relationships to Disclose
 
Marc Van Den Eynde
No Relationships to Disclose
 
Guido Deboever
No Relationships to Disclose
 
Jozef Janssens
No Relationships to Disclose
 
Gauthier Demolin
No Relationships to Disclose
 
Stephane Holbrechts
No Relationships to Disclose
 
Marylene Clausse
No Relationships to Disclose
 
Thierry De Grez
No Relationships to Disclose
 
Joanna Vermeij
No Relationships to Disclose
 
Lionel A. D'Hondt
No Relationships to Disclose
 
Karen Paula Geboes
No Relationships to Disclose
 
Tatiana Besse-Hammer
No Relationships to Disclose
 
Alexis Buggenhout
No Relationships to Disclose
 
Marianne Paesmans
No Relationships to Disclose
 
Martine Piccart
Leadership - Radius Health
Consulting or Advisory Role - AstraZeneca; Camel-IDS; Crescendo Biologics; Debiopharm Group; G1 Therapeutics; HUYA Bioscience International; Immunomedics; Lilly; Menarini; MSD; Novartis; Odonate Therapeutics; Oncolytics; Periphagen; Pfizer; PharmaMar; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Lilly (Inst); M.I.Tech (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); SERVIER (Inst); Synthon (Inst)
 
Patrick Flamen
No Relationships to Disclose